In the summer of 2022, the United States Supreme Court issued a historic decision in Dobbs v. Jackson Women’s Health Organization, striking down Roe v. Wade and allowing states to protect mothers and unborn children. Sadly, the federal government has responded by accelerating its efforts to peddle lethal drugs that kill unborn children and put their mothers at risk.
On Jan. 3, 2023, the Food and Drug Administration changed its regulations to allow retail pharmacies to offer an abortion drug called mifepristone, the first of two drugs commonly used in chemical abortions. Previously, only certified prescribers, clinics, or specific mail-order pharmacies could provide the drug.